Bolcont R

Center for Advanced Medical Psychedelics (CAMP), Natal, Rio Grande do Norte, Brazil.

9 papers · 2 preprints

ArticleKetamine

Dissociation and antidepressant response to subcutaneous esketamine: A clinical study.

Gonçalves KTDC, Tavares VDO, Palhano-Fontes F +12

Europe PMC2026
ArticleDMT

Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression.

Bolcont R, Palhano-Fontes F, Barros H +6

Europe PMC2026
PreprintDMT

DMT, Madness, and Healing: Psychosis Model, Therapy Model, and Their Relations to Mystical Experiences and Positive Emotionality

Wießner I, Falchi-Carvalho M, Laborde S +7

Europe PMC2026
ArticleDMT

Corrigendum to Safety, tolerability and subjective effects of vaporized N, N-Dimethyltryptamine: A randomized double-blind clinical trial [European Neuropsychopharmacology 97 (2025) 16-27].

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2026
ArticleKetamine

Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein.

Cavalcanti-Ribeiro P, De Souza LCAM, de Tavares VDO +11

Europe PMC2026
ArticleDMT

Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial.

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2025
ArticlePsilocybin

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.

Falchi-Carvalho M, Palhano-Fontes F, Wießner I +21

Europe PMC2025
ArticleAyahuasca

The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression.

Falchi-Carvalho M, Barros H, Bolcont R +16

Europe PMC2025
ArticleKetamine

Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.

Palhano-Fontes F, Cavalcanti-Ribeiro P, da Costa Gonçalves KT +13

Europe PMC2025
PreprintAyahuasca

The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression

Falchi-Carvalho M, Barros H, Bolcont R +15

Europe PMC2024
ArticlePsilocybin

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.

Falchi-Carvalho M, Wießner I, Silva SRB +15

Europe PMC2024